Norris Medicines Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	144	168	136	105	350	65
Market Cap Growth	-41.74%	23.38%	30.14%	-70.10%	437.69%	131.32%
Enterprise Value	358	383	351	319	550	241
Last Close Price	14.36	16.78	13.60	10.45	34.95	6.50
PS Ratio	1.97	2.88	2.41	1.25	3.70	0.53
PB Ratio	-0.90	-1.13	-1.00	-0.84	-3.27	-0.87
P/FCF Ratio	20.19	34.17	80.65	8.94	-	6.34
P/OCF Ratio	19.86	32.90	80.11	8.71	-	5.84
EV/Sales Ratio	4.91	6.59	6.23	3.82	5.83	1.96
EV/EBITDA Ratio	-	-	-	34.52	-	-
EV/EBIT Ratio	-	-	-	108.08	-	-
EV/FCF Ratio	50.29	78.09	208.24	27.30	-	23.46
Debt / Equity Ratio	-1.35	-1.45	-1.58	-1.72	-1.97	-2.47
Debt / EBITDA Ratio	-	-	-	23.13	-	-
Debt / FCF Ratio	30.19	43.95	127.63	18.30	-	17.93
Net Debt / Equity Ratio	-1.35	-1.45	-1.58	-1.72	-1.97	-2.47
Net Debt / EBITDA Ratio	-42.51	-97.40	-120.43	23.11	-334.03	-10.54
Net Debt / FCF Ratio	30.10	43.87	127.41	18.28	-19.78	17.91
Asset Turnover	0.55	0.42	0.40	0.60	0.56	0.61
Inventory Turnover	1.12	0.83	0.72	1.25	1.48	1.91
Quick Ratio	0.06	0.14	0.12	0.14	0.16	0.16
Current Ratio	0.57	0.63	0.67	0.64	0.63	0.70
Return on Assets (ROA)	-4.82%	-3.38%	-3.36%	1.32%	-2.65%	-7.46%
Return on Invested Capital (ROIC)	-16.76%	-10.44%	-8.93%	3.06%	-6.76%	-18.30%
Return on Capital Employed (ROCE)	-40.20%	-20.70%	-15.10%	4.90%	-9.70%	-29.80%
Earnings Yield	-10.72%	-7.37%	-8.72%	-16.74%	-9.34%	-76.33%
FCF Yield	4.95%	2.93%	1.24%	11.19%	-3.05%	15.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.